Is Oncolytic Adenoviral-Mediated Immunotherapy Through P53-Overexpression the Solution to Refractory Pancreatic Ductal Adenocarcinoma?
Expert Review of Gastroenterology & Hepatology（2024）
Key words
Adenovirus,immune checkpoint inhibitors,immunotherapy,oncolytic virotherapy,p53,PDAC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined